close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

LLY

1,042.17

-0.56%↓

JNJ

210.98

+0.88%↑

ABBV

224.84

+0.63%↑

UNH

331.47

-0.62%↓

AZN

90.05

-1.5%↓

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

32.16 -2.46

Strong Buy

Prijsupdate 17 dec 2025, 20:50 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

31.96

Max

33.38

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+24.14% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

888M

3B

Vorige openingsprijs

34.62

Vorige sluitingsprijs

32.16

Nieuwssentiment

By Acuity

50%

50%

169 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 dec 2025, 23:46 UTC

Marktinformatie

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

DJ

Lezen

16 dec 2025, 23:38 UTC

Marktinformatie

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

DJ

Lezen

16 dec 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

DJ

Lezen

16 dec 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

DJ

Lezen

16 dec 2025, 22:33 UTC

Acquisities, Fusies, Overnames

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

DJ

Lezen

16 dec 2025, 22:33 UTC

Acquisities, Fusies, Overnames

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

DJ

Lezen

16 dec 2025, 22:32 UTC

Acquisities, Fusies, Overnames

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

DJ

Lezen

16 dec 2025, 22:25 UTC

Acquisities, Fusies, Overnames

Westgold's Indicative Timetable Points to Early February Completion

DJ

Lezen

16 dec 2025, 22:24 UTC

Acquisities, Fusies, Overnames

Westgold: Divestment Aligns With Broader Corporate Strategy

DJ

Lezen

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold: Deferred Payment Based on Performance Hurdles

DJ

Lezen

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

DJ

Lezen

16 dec 2025, 22:23 UTC

Acquisities, Fusies, Overnames

Westgold to Receive A$30M Deferred Payment in Cash or Shares

DJ

Lezen

16 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Westgold Divesting Noncore Operating Asset for A$64.6M

DJ

Lezen

16 dec 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

DJ

Lezen

16 dec 2025, 21:53 UTC

Winsten

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

DJ

Lezen

16 dec 2025, 21:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

16 dec 2025, 21:33 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

DJ

Lezen

16 dec 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

DJ

Lezen

16 dec 2025, 21:17 UTC

Acquisities, Fusies, Overnames

Worthington Enterprises to Buy LSI Group for About $205M >WOR

DJ

Lezen

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q Sales $327.5M >WOR

DJ

Lezen

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q Adj EPS 65c >WOR

DJ

Lezen

16 dec 2025, 21:16 UTC

Winsten

Worthington Enterprises 2Q EPS 55c >WOR

DJ

Lezen

16 dec 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

DJ

Lezen

16 dec 2025, 21:05 UTC

Acquisities, Fusies, Overnames

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

DJ

Lezen

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

DJ

Lezen

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

DJ

Lezen

16 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

DJ

Lezen

16 dec 2025, 20:44 UTC

Marktinformatie

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

DJ

Lezen

16 dec 2025, 20:04 UTC

Marktinformatie

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

DJ

Lezen

16 dec 2025, 20:01 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

24.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 40.78 USD  24.14%

Hoogste 61 USD

Laagste 14.317 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

15

Buy

0

Hold

0

Sell

Gebaseerd op 15 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

169 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,042.17

↓-0.56%

JNJ

Johnson and Johnson

210.98

↑ +0.88%

ABBV

AbbVie Inc

224.84

↑ +0.63%

UNH

UnitedHealth Group Inc

331.47

↓-0.62%

AZN

AstraZeneca PLC ADR

90.05

↓-1.5%
help-icon Live chat